Associations of specific dietary unsaturated fatty acids with risk of overweight/obesity: population-based cohort study.
China health and nutrition survey
obesity
overweight
prospective study
unsaturated fatty acids
Journal
Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264
Informations de publication
Date de publication:
2023
2023
Historique:
received:
24
01
2023
accepted:
02
05
2023
medline:
26
6
2023
pubmed:
26
6
2023
entrez:
26
6
2023
Statut:
epublish
Résumé
The role of specific unsaturated fatty acids (FAs) in the development of overweight/obesity remains unclear in the general population. Here, we aimed to explore the associations of different types of unsaturated FAs with overweight/obesity risk among the Chinese population. Eight thousand seven hundred forty-two subjects free of overweight/obesity at entry in the China Health and Nutrition Survey (CHNS) were followed up until 2015. Dietary unsaturated FAs were assessed by 3-day 24-h recalls with a weighing method in each wave. Cox regression models were used to obtain the hazard ratios (HRs) and 95% confidence intervals (CIs) for overweight/obesity risk associated with unsaturated FAs. During a median follow-up of 7 years, 2,753 subjects (1,350 males and 1,403 females) developed overweight/obesity. Consuming more monounsaturated FAs (MUFAs) was associated with a lower risk of overweight/obesity (highest vs. lowest quartile: HR 0.80, 95% CI 0.67-0.96; Higher dietary intake of MUFAs was associated with lower overweight/obesity risk, which was mainly driven by dietary OA from either plant or animal sources. Intakes of ALA, n-6 PUFAs and LA were related to higher risk of overweight/obesity. These results support consuming more MUFAs for maintaining a healthy body weight among the Chinese population.
Sections du résumé
Background
UNASSIGNED
The role of specific unsaturated fatty acids (FAs) in the development of overweight/obesity remains unclear in the general population. Here, we aimed to explore the associations of different types of unsaturated FAs with overweight/obesity risk among the Chinese population.
Methods
UNASSIGNED
Eight thousand seven hundred forty-two subjects free of overweight/obesity at entry in the China Health and Nutrition Survey (CHNS) were followed up until 2015. Dietary unsaturated FAs were assessed by 3-day 24-h recalls with a weighing method in each wave. Cox regression models were used to obtain the hazard ratios (HRs) and 95% confidence intervals (CIs) for overweight/obesity risk associated with unsaturated FAs.
Results
UNASSIGNED
During a median follow-up of 7 years, 2,753 subjects (1,350 males and 1,403 females) developed overweight/obesity. Consuming more monounsaturated FAs (MUFAs) was associated with a lower risk of overweight/obesity (highest vs. lowest quartile: HR 0.80, 95% CI 0.67-0.96;
Conclusion
UNASSIGNED
Higher dietary intake of MUFAs was associated with lower overweight/obesity risk, which was mainly driven by dietary OA from either plant or animal sources. Intakes of ALA, n-6 PUFAs and LA were related to higher risk of overweight/obesity. These results support consuming more MUFAs for maintaining a healthy body weight among the Chinese population.
Identifiants
pubmed: 37360299
doi: 10.3389/fnut.2023.1150709
pmc: PMC10285060
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1150709Informations de copyright
Copyright © 2023 Chen, Ao, Lan, Tong, Liu, Zhang, Ye, Li, Liu, Ye, Zhuang, Zhang, Zheng and Jiao.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nutrients. 2017 Apr 28;9(5):
pubmed: 28452961
Eur J Nutr. 2020 Aug;59(5):1989-1998
pubmed: 31297602
Public Health Nutr. 2010 Oct;13(10):1636-46
pubmed: 20074389
Am J Epidemiol. 2022 Apr 14;:
pubmed: 35419586
Eur J Nutr. 2016 Mar;55(2):687-697
pubmed: 25820817
Mol Nutr Food Res. 2019 Jul;63(14):e1801135
pubmed: 31140724
Prostaglandins Other Lipid Mediat. 2016 Sep;125:90-9
pubmed: 27350414
Lipids Health Dis. 2020 Apr 27;19(1):80
pubmed: 32340620
Am J Physiol Endocrinol Metab. 2017 Dec 1;313(6):E710-E720
pubmed: 28851735
Appetite. 2013 Jun;65:1-7
pubmed: 23376733
Br J Nutr. 2020 Jul 14;124(1):102-111
pubmed: 32102700
Lancet Diabetes Endocrinol. 2021 Jun;9(6):373-392
pubmed: 34022156
Nutrients. 2016 Mar 02;8(3):128
pubmed: 26950145
J Nutr Biochem. 2019 Nov;73:108226
pubmed: 31520815
Obes Rev. 2014 Jan;15 Suppl 1:2-7
pubmed: 24341753
Am J Clin Nutr. 2000 Oct;72(4):905-11
pubmed: 11010930
Prostaglandins Leukot Essent Fatty Acids. 2018 May;132:34-40
pubmed: 29599053
Nutr Res. 2017 Dec;48:85-92
pubmed: 29246284
PLoS One. 2015 Jul 22;10(7):e0132672
pubmed: 26200659
Food Funct. 2020 Jul 22;11(7):6158-6169
pubmed: 32578655
J Nutr Biochem. 2020 Oct;84:108458
pubmed: 32738734
Mol Nutr Food Res. 2016 Apr;60(4):886-96
pubmed: 26821227
Circulation. 2021 May 25;143(21):e984-e1010
pubmed: 33882682
JPEN J Parenter Enteral Nutr. 2015 Sep;39(1 Suppl):18S-32S
pubmed: 26177664
Br J Nutr. 2022 Jul 14;128(1):75-83
pubmed: 34338170
Public Health Nutr. 2017 Nov;20(16):2927-2936
pubmed: 28789722
Crit Rev Food Sci Nutr. 2019;59(10):1619-1644
pubmed: 29359954
J Nutr. 2017 Nov;147(11):2102-2108
pubmed: 28978676
Br J Nutr. 2015 Apr;113 Suppl 2:S36-48
pubmed: 26148920
Am J Clin Nutr. 2014 Mar;99(3):436-45
pubmed: 24429541
Metabolism. 2019 Mar;92:121-135
pubmed: 30445141
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33393504
Food Funct. 2015 Jan;6(1):204-10
pubmed: 25347552
Adv Nutr. 2020 Jul 1;11(4):864-877
pubmed: 32135008
J Nutr. 2021 Apr 8;151(4):970-978
pubmed: 33561215
Am J Clin Nutr. 2018 Mar 1;107(3):445-453
pubmed: 29566185
Int J Epidemiol. 2010 Dec;39(6):1435-40
pubmed: 19887509